L Jay Katz, Camila Zangalli, Raymond Clifford, Benjamin Leiby
{"title":"Combined cataract and glaucoma surgery: the effect of pupil enlargement on surgical outcomes (an American Ophthalmological Society thesis).","authors":"L Jay Katz, Camila Zangalli, Raymond Clifford, Benjamin Leiby","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine whether pupil enlargement during phacotrabeculectomy affects postoperative visual acuity and intraocular pressure (IOP) compared to combined surgery without pupil enlargement.</p><p><strong>Methods: </strong>A retrospective study of 74 patients who underwent combined phacotrabeculectomy with (37 eyes) or without (37 eyes) pupil enlargement was performed. Postoperative outcome measures included best-corrected visual acuity (BCVA), IOP, number of medications, and complications up to 6 months. Wilcoxon-Mann-Whitney test was used to compare outcomes between groups.</p><p><strong>Results: </strong>Demographic characteristics of the two groups were similar except for diagnosis; chronic angle-closure glaucoma and pseudoexfoliation syndrome were more common in the pupil enlargement group. Preoperatively, the pupil enlargement group had a mean IOP of 21.2 ± 6.6 mm Hg compared to 21.1 ± 6.4 mm Hg for the control group (P=.978, Wilcoxon-Mann-Whitney test). Mean preoperative logMAR equivalent (BCVA) was 0.68 ± 0.67 and 0.63 ± 0.59, respectively (P=.727, Wilcoxon-Mann-Whitney test). At 6 months, mean IOP was 15.5 ± 5.6 mm Hg in the study group and 13.3 ± 4.5 mm Hg in the control group (P=.039, Wilcoxon-Mann-Whitney test). Mean postoperative vision at 6 months was better in the control group (0.36 ± 0.48) vs pupil enlargement group (0.51 ± 0.66) but not statistically different (P=.324 Wilcoxon-Mann-Whitney test). The groups did not differ in number of postoperative glaucoma medications. Complications were rare in both groups.</p><p><strong>Conclusion: </strong>The results of this study suggest that the outcomes of combined phacoemulsification and trabeculectomy are not adversely impacted by pupil enlargement, although IOP control may be relatively impaired.</p>","PeriodicalId":23166,"journal":{"name":"Transactions of the American Ophthalmological Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868408/pdf/1545-6110_v111_p155.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transactions of the American Ophthalmological Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To determine whether pupil enlargement during phacotrabeculectomy affects postoperative visual acuity and intraocular pressure (IOP) compared to combined surgery without pupil enlargement.
Methods: A retrospective study of 74 patients who underwent combined phacotrabeculectomy with (37 eyes) or without (37 eyes) pupil enlargement was performed. Postoperative outcome measures included best-corrected visual acuity (BCVA), IOP, number of medications, and complications up to 6 months. Wilcoxon-Mann-Whitney test was used to compare outcomes between groups.
Results: Demographic characteristics of the two groups were similar except for diagnosis; chronic angle-closure glaucoma and pseudoexfoliation syndrome were more common in the pupil enlargement group. Preoperatively, the pupil enlargement group had a mean IOP of 21.2 ± 6.6 mm Hg compared to 21.1 ± 6.4 mm Hg for the control group (P=.978, Wilcoxon-Mann-Whitney test). Mean preoperative logMAR equivalent (BCVA) was 0.68 ± 0.67 and 0.63 ± 0.59, respectively (P=.727, Wilcoxon-Mann-Whitney test). At 6 months, mean IOP was 15.5 ± 5.6 mm Hg in the study group and 13.3 ± 4.5 mm Hg in the control group (P=.039, Wilcoxon-Mann-Whitney test). Mean postoperative vision at 6 months was better in the control group (0.36 ± 0.48) vs pupil enlargement group (0.51 ± 0.66) but not statistically different (P=.324 Wilcoxon-Mann-Whitney test). The groups did not differ in number of postoperative glaucoma medications. Complications were rare in both groups.
Conclusion: The results of this study suggest that the outcomes of combined phacoemulsification and trabeculectomy are not adversely impacted by pupil enlargement, although IOP control may be relatively impaired.
目的:探讨超声小梁切除术中瞳孔扩大与不扩大瞳孔的联合手术相比,是否会影响术后的视力和眼压。方法:回顾性分析74例合并(37眼)或未(37眼)瞳孔扩大的患者。术后结果测量包括最佳矫正视力(BCVA)、IOP、药物数量和6个月前的并发症。采用Wilcoxon-Mann-Whitney检验比较各组间结果。结果:两组除诊断外,人口学特征相似;慢性闭角型青光眼和假角质脱落综合征在瞳孔扩大组中更为常见。术前,瞳孔扩大组平均IOP为21.2±6.6 mm Hg,对照组为21.1±6.4 mm Hg (P=;978, Wilcoxon-Mann-Whitney test)。术前平均logMAR当量(BCVA)分别为0.68±0.67和0.63±0.59 (P=。727, Wilcoxon-Mann-Whitney test)。6个月时,研究组平均IOP为15.5±5.6 mm Hg,对照组平均IOP为13.3±4.5 mm Hg (P=。039, Wilcoxon-Mann-Whitney test)。对照组术后6个月平均视力(0.36±0.48)优于瞳孔扩大组(0.51±0.66),差异无统计学意义(P=.324)Wilcoxon-Mann-Whitney测试)。两组术后青光眼药物的数量没有差异。两组并发症均罕见。结论:本研究结果提示,尽管IOP控制可能相对受损,但联合超声乳化术和小梁切除术的结果并未受到瞳孔扩大的不利影响。